Labs race to make pharmaceutical MDMA available to treat mental illness

Filament Health Announces Signing Of Definitive Agreement for Convertible Note Financing, Closing of C$900,000 Non-Brokered Private Placement Financing, Founder-Led Note Offering, And Other Updates Related To Proposed Business Combination

Filament Health Signs Non-Binding Term Sheet For Convertible Note In Connection With Planned Business Combination

Canadians deserve equitable access to psychedelic-assisted therapy